Gline Matthew
Roivant Sciences Ltd. - Common Shares · CEO
Gline Matthew is listed in filings as CEO at Roivant Sciences Ltd. - Common Shares. This profile follows SEC Form 4 activity through Apr 20, 2026, including purchase activity and sale activity. Recent filings connect the profile to Roivant Sciences Ltd. - Common Shares (ROIV). The current snapshot covers public activity from May 22, 2025 to Apr 20, 2026. Reported amounts are shown as $120.8K to $28.8M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $50k3.3k shares | BuySep 18, 2025 | $15.07 | $34.96 | |
| $5M230.4k shares | SellDec 15, 2025 | $21.68 | $34.96 | |
| $12M566.1k shares | SellDec 15, 2025 | $21.68 | $34.96 | |
| $20M943.5k shares | SellDec 15, 2025 | $21.68 | $34.96 |